Sign in
4

Changes in Ownership

Kairos Pharma, LTD. Filed Acc 0001493152-24-047261

CEO and Chairman bought 4,000 shares at $1.44 ($5,760)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Yu John S CEO and Chairman 2024-11-20 Purchase +4,000 $1.44 $5,760 5,341,837 D
Open-market purchases · 4,000 sh · avg $1.44 · $5,760
Loading xslF345X05/ownership.xml…